This program is designed to help NIH Phase II awardees transition their SBIR-STTR-developed products into the marketplace by providing companies with individualized assistance toward accomplishing their regulatory and commercialization goals.
This program is designed to help NIH Phase II awardees transition their SBIR-STTR-developed products into the marketplace by providing companies with individualized assistance toward accomplishing their regulatory and commercialization goals.